Skip to Content

Sumavel DosePro Approval History

  • FDA approved: Yes (First approved July 15th, 2009)
  • Brand name: Sumavel DosePro
  • Generic name: sumatriptan
  • Dosage form: Injection
  • Company: Zogenix, Inc.
  • Treatment for: Migraine, Cluster Headaches

Sumavel DosePro (sumatriptan injection) is a needle-free delivery system to treat acute migraine, with or without aura, and cluster headache.

Development History and FDA Approval Process for Sumavel DosePro

Jul 16, 2009Approval Sumavel DosePro (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Feb 18, 2009Zogenix Reports FDA Provides New PDUFA Date for Sumavel DosePro

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.